MYSM1 is required for the activation of several target genes in prostate cancer cells and the levels of monoubiquitinylated H2A are dramatically decreased in prostate tumors [1], suggesting MYSM1 expression may be involved in tumor biological functions. The gene discussed is MYSM1; the disease is neoplasm.